Stryker Profile (Large Joints): Global Market Share Analysis by Region, SWOT, Product Pipeline & Financials

In 2011, Stryker’s spinal division grew by over 48% from 2010, boosted by the acquisition of Boston Scientific’s neurovascular asset. Stryker earned over $8 billion (US$) in 2011, an increase of more than 13% in total revenue over 2010. While most of its revenue was earned from its reconstructive unit, the MedSurg sector was a close second, and grew at a faster rate. Stryker’s spinal unit was the fastestgrowing division, and was boosted by the acquisition of Boston Scientific’s neurovascular asset. The company’s net earnings declined in 2011 from the previous year, but the company’s acquisitions helped contribute to overall sales growth.The information covered includes:

• An overview of the company history and current product divisions
• A summary of corporate financial metrics
• A review of recently approved products and the results of preliminary clinical trials
• An in-depth review of the strengths, weaknesses opportunities and threats (SWOT) to the company's orthopedic biomaterials divisions
• A detailed look at the market share and performance of each division in various countries across the U.S., Europe and Asia. Whenever possible, market share and division revenues are examined by individual country for each region of the globe.

Table Of contents

EXECUTIVE SUMMARY
1.1 STRYKER OVERVIEW
1.2 CORPORATE REVENUE GROWTH BY BUSINESS UNIT
1.3 GLOBAL REVENUE BY REGION

RESEARCH METHODOLOGY
2.1 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

STRYKER COMPANY OVERVIEW
3.1 INTRODUCTION
3.2 COMPANY PROFILE
3.2.1 Business Units
3.2.1.1 Reconstructive
3.2.1.2 Medical and Surgical
3.2.1.3 Neurotechnology and Spine
3.3 GLOBAL REVENUES
3.3.1 Global Revenues by Division
3.3.2 Global Sales by Geography
3.4 COMPANY HISTORY
3.5 COMPANY INFORMATION
3.5.1 Size
3.5.2 Office and Facility Locations

FINANCIAL METRICS
4.1 INCOME STATEMENT
4.2 BALANCE SHEET
4.2.1 Balance Sheet
4.2.2 Company Debt

PRODUCT PIPELINE
5.1 LARGE JOINT RECONSTRUCTION
5.1.1 U.S. FDA 510(k) Approvals for 2011
5.1.1.1 Exeter X3® Rimfit Acetabular Cup
5.1.1.2 ABG™ 11 Monolithic Hip Stem
5.1.1.3 Stryker® Patient Specific Cutting Guide
5.1.1.4 AxSOS™ Locking Plate System

SWOT ANALYSIS
6.1 LARGE JOINT RECONSTRUCTION SWOT ANALYSIS
6.1.1 Strengths
6.1.2 Weaknesses
6.1.3 Opportunities
6.1.4 Threats

LARGE JOINT RECONSTRUCTION MARKET SHARE ANALYSIS
7.1 MARKET INTRODUCTION
7.1.1 Knee Reconstruction
7.1.1.1 Anatomy
7.1.1.2 Pathology
7.1.1.3 Implant Types
7.1.1.3.1 Total Knee Replacement
7.1.1.3.2 Partial Knee Replacement
7.1.1.3.3 Patellofemoral Replacement
7.1.1.3.4 Interpositional Knee Implants
7.1.1.3.5 Knee Revision
7.1.1.4 Fixation Method
7.1.1.5 Bearing Surface
7.1.1.6 Fixed Versus Mobile Bearings
7.1.2 Hip Reconstruction
7.1.2.1 Anatomy
7.1.2.2 Pathology
7.1.2.3 Treatment
7.1.2.4 Implant Types
7.1.2.4.1 Total Hip Joint Replacement
7.1.2.4.2 Partial Hip Joint Replacement
7.1.2.4.3 Resurfacing Hip Joint Replacement
7.1.2.4.4 Revision Hip Joint Replacement
7.1.2.5 Fixation Method
7.1.2.6 Implant Material
7.1.2.7 Bearing Surface Technology
7.1.2.7.1 Polyethylene Bearings
7.1.2.7.2 Highly Cross-Linked Polyethylene Bearings
7.1.2.7.3 Metal Bearings
7.1.2.7.4 Ceramic Bearings
7.2 MARKET SHARE AND REVENUE ANALYSIS
7.2.1 Combined Large Joint Reconstruction
7.2.1.1 Global Market Share
7.2.1.2 U.S. Market Share
7.2.1.3 European Market Share by Country
7.2.1.4 European Market Share by Country
7.2.1.5 Asia-Pacific Market Share by Country
7.2.2 Hip Reconstruction
7.2.2.1 U.S. and Global Market Share
7.2.2.2 European Market Share by Country
7.2.2.3 Asia-Pacific Market Share by Country
7.2.3 Knee Reconstruction
7.2.3.1 U.S. and Global Market Share
7.2.3.2 European Market Share by Country
7.2.3.3 Asia-Pacific Market Share by Country

ABBREVIATIONS